An Act relating to the Patient’s Right to Pharmacy Choice Act; amending Section 3, Chapter 426, O.S.L. 2019 (36 O.S. Supp. 2020, Section 6960), which relates to definitions; adding definitions of pharmacy benefits management and retail pharmacy; modifying definitions; amending Section 4, Chapter 426, O.S.L. 2019 (36 O.S. Supp. 2020, Section 6961), which relates to retail pharmacy network access standards; specifying access standards; modifying prohibition by pharmacy benefit managers; amending Section 5, Chapter 426, O.S.L. 2019 (36 O.S. Supp. 2020, Section 6962), which relates to compliance review; modifying certain contract restrictions; amending Section 6, Chapter 426, O.S.L. 2019 (36 O.S. Supp. 2020, Section 6963), which relates to health insurer monitoring; modifying monitoring requirements of certain insurers; conforming language; repealing Section 7, Chapter 426, O.S.L. 2019 (36 O.S. Supp. 2020, Section 6964), which relates to health insurer formularies; and providing an effective date.